| 1 |
33588740 | Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance. | 2022 |
2 |
| 2 |
33556804 | A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan. | 2021 May |
1 |
| 3 |
33572654 | Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis. | 2021 Jan 31 |
1 |
| 4 |
33976181 | Macrocyclic peptides exhibit antiviral effects against influenza virus HA and prevent pneumonia in animal models. | 2021 May 11 |
1 |
| 5 |
34161726 | Design of Neuraminidase-Targeted Imaging and Therapeutic Agents for the Diagnosis and Treatment of Influenza Virus Infections. | 2021 Aug 18 |
4 |
| 6 |
34179969 | Neuraminidase 1 is a driver of experimental cardiac hypertrophy. | 2021 Sep 21 |
1 |
| 7 |
31368872 | Potential Role of Endonuclease Inhibition and Other Targets in the Treatment of Influenza. | 2020 |
1 |
| 8 |
31664778 | Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza. | 2020 Jan |
1 |
| 9 |
31955521 | Antigenic variants of influenza B viruses isolated in Japan during the 2017-2018 and 2018-2019 influenza seasons. | 2020 May |
1 |
| 10 |
32178606 | Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2018. | 2020 Mar 16 |
1 |
| 11 |
32394467 | A global treatments for coronaviruses including COVID-19. | 2020 Dec |
1 |
| 12 |
33154358 | A universal dual mechanism immunotherapy for the treatment of influenza virus infections. | 2020 Nov 5 |
1 |
| 13 |
30739429 | Annual report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2016 | 2019 Feb 1 |
1 |
| 14 |
31203585 | Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza in 2017 | 2019 Jun 17 |
1 |
| 15 |
32031540 | Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient. | 2019 |
1 |
| 16 |
32598620 | [Review of current and future directions of antiviral therapy of influenza and acute respiratory viral infections in Russia]. | 2019 Nov 15 |
2 |
| 17 |
29212895 | Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases. | 2018 Mar 27 |
1 |
| 18 |
29397718 | Structural and Functional Analysis of Anti-Influenza Activity of 4-, 7-, 8- and 9-Deoxygenated 2,3-Difluoro- N-acetylneuraminic Acid Derivatives. | 2018 Mar 8 |
1 |
| 19 |
28315686 | Crystal structure of the catalytic domain of Clostridium perfringens neuraminidase in complex with a non-carbohydrate-based inhibitor, 2-(cyclohexylamino)ethanesulfonic acid. | 2017 Apr 29 |
2 |
| 20 |
28502901 | Neuraminidase activity of blue eye disease porcine rubulavirus: Specificity, affinity and inhibition studies. | 2017 Oct |
1 |
| 21 |
28655817 | Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited. | 2017 Jun 27 |
1 |
| 22 |
28899310 | Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2015. | 2017 Jun 30 |
1 |
| 23 |
29269445 | Recurrent infection progressively disables host protection against intestinal inflammation. | 2017 Dec 22 |
1 |
| 24 |
26905631 | Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. | 2016 Feb 24 |
1 |
| 25 |
27341624 | Structure-Based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-Resistant Influenza Viruses. | 2016 Jul 14 |
8 |
| 26 |
27539435 | Identification of single amino acid substitutions (SAAS) in neuraminidase from influenza a virus (H1N1) via mass spectrometry analysis coupled with de novo peptide sequencing. | 2016 Aug |
1 |
| 27 |
27845731 | Influenza Neuraminidase Inhibitors: Synthetic Approaches, Derivatives and Biological Activity. | 2016 Nov 11 |
2 |
| 28 |
25470818 | Evaluation of safety and efficacy of intravenous zanamivir in the treatment of hospitalized Japanese patients with influenza: an open-label, single-arm study. | 2015 |
1 |
| 29 |
25673705 | Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium. | 2015 Apr |
1 |
| 30 |
25703253 | Neuraminidase inhibitors: who, when, where? | 2015 Mar |
1 |
| 31 |
25980910 | Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay. | 2015 Jun 15 |
1 |
| 32 |
26164940 | [Susceptibility of Influenza B Viruses to Neuraminidase Inhibitors Isolated during 2013-2014 Influenza Season in Mainland China]. | 2015 Mar |
1 |
| 33 |
27004397 | [Comparison of the clinical effectiveness of three neuraminidase inhibitors for Japanese pediatric patients with influenza in the 2013/2014 season]. | 2015 Dec |
1 |
| 34 |
23983212 | Safety and pharmacokinetics of intravenous zanamivir treatment in hospitalized adults with influenza: an open-label, multicenter, single-arm, phase II study. | 2014 Feb 15 |
1 |
| 35 |
24001233 | Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1. | 2014 |
2 |
| 36 |
24515341 | Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis. | 2014 Feb 10 |
1 |
| 37 |
24560563 | In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan. | 2014 Feb |
1 |
| 38 |
24787736 | Spread of viral infection to family members from influenza patients treated with a neuraminidase inhibitor. | 2014 Jul |
1 |
| 39 |
24941871 | From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs? | 2014 May |
1 |
| 40 |
25163170 | Development of 3D-QSAR combination approach for discovering and analysing neuraminidase inhibitors in silico. | 2014 |
1 |
| 41 |
25314609 | Organocatalytic and scalable synthesis of the anti-influenza drugs zanamivir, laninamivir, and CS-8958. | 2014 Dec 8 |
1 |
| 42 |
25352629 | Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. | 2014 Nov 15 |
1 |
| 43 |
23150231 | Chemical probes for drug-resistance assessment by binding competition (RABC): oseltamivir susceptibility evaluation. | 2013 Jan 2 |
2 |
| 44 |
23357777 | Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets. | 2013 Apr |
1 |
| 45 |
23363310 | European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. | 2013 Jun |
1 |
| 46 |
23369206 | Recent progress and challenges in the discovery of new neuraminidase inhibitors. | 2013 Apr |
1 |
| 47 |
23422659 | Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors. | 2013 |
1 |
| 48 |
23429702 | Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity. | 2013 Apr 5 |
1 |
| 49 |
23553534 | Effect of intravenous zanamivir on cardiac repolarization. | 2013 Jul |
1 |
| 50 |
23726392 | Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. | 2013 Jun 29 |
2 |